BioMed Research International / 2013 / Article / Tab 2

Clinical Study

Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool

Table 2

Parameters for organs at risk (OAR) during HT planning.

OARPriorityBlockingImportanceHistogram dose-volume points

Contralateral lung1Directional10005%-7 Gy
30%-3 Gy
50%-2 Gy
Heart2Directional100015%-10 Gy
5%-15 Gy
Homolateral lung3Directional100050%-5 Gy
15%-20 Gy
5%-30 Gy
Contralateral breast4Directional100010%-3 Gy
Spinal cord5Directional30030%-10 Gy
Liver6Directional30020%-5 Gy

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.